Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature
{{output}}
Introduction: Pimavanserin (Nuplazid™) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis. The antipsychotic effects of this new agent a... ...
